Posters - NCDEU: An Annual Meeting Sponsored by ASCP
Posters - NCDEU: An Annual Meeting Sponsored by ASCP
Posters - NCDEU: An Annual Meeting Sponsored by ASCP
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Posters</strong><br />
67. Adjunctive Lisdexamfetamine Dimesylate Treatment of<br />
Predominant Negative Symptoms of Schizophrenia: Post-hoc<br />
<strong>An</strong>alysis <strong>by</strong> Global Improvement Criteria<br />
Jean-Pierre Lindenmayer, New York University School of Medicine<br />
Bryan Dirks, Henry Nasrallah, Courtney Kirsch, Ben Adeyi, Brian<br />
Scheckner, Robert Lasser<br />
68. Lurasidone vs. Quetiapine XR For Relapse Prevention In<br />
Schizophrenia: A 12-Month, Double-Blind Study<br />
<strong>An</strong>thony Loebel, Sunovion Pharmaceuticals, Inc.<br />
Josephine Cucchiaro, Jane Xu, Kaushik Sarma, <strong>An</strong>drei Pikalov, John<br />
Kane<br />
69. Open Board<br />
70. Effects of a Long-acting Injectable Formulation of Aripiprazole<br />
on Secondary Efficacy Outcomes in Maintenance Treatment of<br />
Schizophrenia<br />
Pam Perry, Otsuka Pharmaceutical Development and<br />
Commercialization, Inc.<br />
William Carson, Raymond Sanchez, Na Jin, Robert Forbes, Robert<br />
McQuade, Wolfgang Fleischhacker, John Kane<br />
71. Assessment of Change in Body Weight after <strong>An</strong>tipsychotic<br />
Treatment is Confounded <strong>by</strong> Regression to the Mean<br />
Cynthia Siu, Data Power (DP), Inc.<br />
Jane Xu, Josephine Cucchiaro, <strong>An</strong>drei Pikalov, <strong>An</strong>tony Loebel<br />
72. <strong>An</strong> Evaluation of the Psychometric Properties of the Brief<br />
Negative Symptom Scale (BNSS) in Individuals with Schizophrenia<br />
Gregory Strauss, University of Maryland School of Medicine<br />
Lauren Catalano, James Gold, William Keller, Robert Buchanan,<br />
William Carpenter, Brian Kirkpatrick<br />
73. The Evaluation of Negative Symptoms <strong>by</strong> Videoconferencing in a<br />
Clinical Trial<br />
Janet Williams, MedAvante, Inc., Department of Psychiatry, Columbia<br />
University<br />
Danielle Popp, Douglas Osman, Elan Cohen, Michael Detke<br />
74. Open Board<br />
= New Investigator Awardee<br />
91
Change language